SEC14L3 and nonpapillary renal cell carcinoma: To validate the impact of SEC14L3 on ccRCC cell proliferation in vivo, we subcutaneously injected SEC14L3 KD A-498 cells and corresponding negative control (NC) cells into BALB/c nude mice.